- Creation of subsidiary companies with targeted market focuses: Mirexus Inc. (Personal Care), Glysantis Inc. (Biomedical).
- Series A investment led by Goddard Enterprises Ltd and Asahi Kasei Ltd.
- Partnership with GreenSky Capital and raised its first round of Angel investment. Greg Stewart also joined Mirexus as CFO.
-
Dr. Phil Whiting joined Mirexus as CEO, and the focus turned to commercialization of PhytoSpherix®.
- Research to characterize the unique and surprising properties of PhytoSpherix®, and to discover its potential applications.
- Mirexus was started after researchers isolated monodisperse PhytoSpherix® in corn.
-
Researchers in the lab of Dr. John Dutcher at the University of Guelph discovered the material PhytoSpherix® unexpectedly as part of a collaborative project between Dr. Dutcher and Dr. Terry Beveridge.
